Core scRNA-seq Assay Kits

About Fluent BioSciences

Fluent BioSciences is a private, early-stage company positioned in the rapidly growing single-cell analysis market. Its core innovation is an instrument-free platform for scRNA-seq, aiming to reduce the cost, complexity, and specialized equipment barriers associated with current technologies. By providing integrated kits and analysis software like PIPseeker™, the company targets academic, biopharma, and diagnostic labs seeking more accessible single-cell insights. Success hinges on widespread adoption of its simplified workflow against established, instrument-dependent competitors.